C266H308F9N87O24S9 — CID 167695056
tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[3-[(5-methyl-1H-pyrazol-3-yl)amino]-8-oxo-7H-2,7-naphthyridin-1-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[6-[(5-methyl-1H-pyrazol-3-yl)amino]-4-oxo-3H-pyrido[3,4-d]pyrimidin-8-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[7-[(5-methyl-1H-pyrazol-3-yl)amino]pyrido[3,4-b]pyrazin-5-yl]cyclohexane-1-carboxamide);methane;sulfane (PubChem CID 167695056) has the molecular formula C266H308F9N87O24S9 and a molecular weight of 5567.56 g/mol. Its IUPAC name is tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[3-[(5-methyl-1H-pyrazol-3-yl)amino]-8-oxo-7H-2,7-naphthyridin-1-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[6-[(5-methyl-1H-pyrazol-3-yl)amino]-4-oxo-3H-pyrido[3,4-d]pyrimidin-8-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[7-[(5-methyl-1H-pyrazol-3-yl)amino]pyrido[3,4-b]pyrazin-5-yl]cyclohexane-1-carboxamide);methane;sulfane.
| Compound Name | tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[3-[(5-methyl-1H-pyrazol-3-yl)amino]-8-oxo-7H-2,7-naphthyridin-1-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[6-[(5-methyl-1H-pyrazol-3-yl)amino]-4-oxo-3H-pyrido[3,4-d]pyrimidin-8-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[7-[(5-methyl-1H-pyrazol-3-yl)amino]pyrido[3,4-b]pyrazin-5-yl]cyclohexane-1-carboxamide);methane;sulfane |
|---|---|
| PubChem CID | 167695056 |
| Molecular Formula | C266H308F9N87O24S9 |
| Molecular Weight | 5567.56 g/mol |
| Exact Mass | 5563.29 |
| IUPAC Name | tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[3-[(5-methyl-1H-pyrazol-3-yl)amino]-8-oxo-7H-2,7-naphthyridin-1-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[6-[(5-methyl-1H-pyrazol-3-yl)amino]-4-oxo-3H-pyrido[3,4-d]pyrimidin-8-yl]cyclohexane-1-carboxamide);tris(N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[7-[(5-methyl-1H-pyrazol-3-yl)amino]pyrido[3,4-b]pyrazin-5-yl]cyclohexane-1-carboxamide);methane;sulfane |
| SMILES | C.C.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3c(=O)[nH]cnc23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3c(=O)[nH]cnc23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3c(=O)[nH]cnc23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3cc[nH]c(=O)c23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3cc[nH]c(=O)c23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3cc[nH]c(=O)c23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3nccnc23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3nccnc23)CC1.COC1(C(=O)N[C@@H](C)c2ccc(-n3cc(F)cn3)nc2)CCC(c2nc(Nc3cc(C)[nH]n3)cc3nccnc23)CC1.S.S.S.S.S.S.S.S.S |
| InChI | InChI=1S/3C30H32FN9O3.3C29H31FN10O3.3C29H31FN10O2.2CH4.9H2S/c3*1-17-12-24(39-38-17)36-23-13-20-8-11-32-28(41)26(20)27(37-23)19-6-9-30(43-3,10-7-19)29(42)35-18(2)21-4-5-25(33-14-21)40-16-22(31)15-34-40;3*1-16-10-23(39-38-16)36-22-11-21-26(32-15-33-27(21)41)25(37-22)18-6-8-29(43-3,9-7-18)28(42)35-17(2)19-4-5-24(31-12-19)40-14-20(30)13-34-40;3*1-17-12-24(39-38-17)36-23-13-22-27(32-11-10-31-22)26(37-23)19-6-8-29(42-3,9-7-19)28(41)35-18(2)20-4-5-25(33-14-20)40-16-21(30)15-34-40;;;;;;;;;;;/h3*4-5,8,11-16,18-19H,6-7,9-10H2,1-3H3,(H,32,41)(H,35,42)(H2,36,37,38,39);3*4-5,10-15,17-18H,6-9H2,1-3H3,(H,35,42)(H,32,33,41)(H2,36,37,38,39);3*4-5,10-16,18-19H,6-9H2,1-3H3,(H,35,41)(H2,36,37,38,39);2*1H4;9*1H2/t3*18-,19?,30?;3*17-,18?,29?;3*18-,19?,29?;;;;;;;;;;;/m000000000.........../s1 |
| InChIKey | XNJBBWORHUWKHC-DIILNZKESA-N |
| XLogP | 39.82 |
| TPSA | 1416.93 Ų |
| H-Bond Donors | 33 |
| H-Bond Acceptors | 87 |
| Rotatable Bonds | 72 |
| Heavy Atoms | 395 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 5567.56 |
| LogP ≤ 5 | 39.82 |
| H-Bond Donors ≤ 5 | 33 |
| H-Bond Acceptors ≤ 10 | 87 |